Screener
Nuvation Bio NUVB Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses | 45,204 | 45,183 |
| Total current liabilities | 86,755 | 82,231 |
| Contract liabilities, net of current portion | 8,228 | 11,305 |
| Non-current operating lease liabilities | 1,910 | 2,543 |
| Non-current liability related to revenue interest financing agreement, net of deferred financing costs of $3,818 and $4,241, respectively | 151,122 | 145,819 |
| Long-term borrowings, net of deferred financing costs of $3,042 | — | 47,208 |
| Convertible debt, net of deferred financing costs of $7,376 | 242,624 | — |
| Total liabilities | 490,639 | 289,106 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's operating lease liabilities?
- Nuvation Bio (NUVB) reported operating lease liabilities of $1.91M in Q2 2026.
- How has Nuvation Bio's operating lease liabilities changed year-over-year?
- Nuvation Bio's operating lease liabilities decreased by 43.8% year-over-year, from $3.4M to $1.91M.
- What is the long-term trend for Nuvation Bio's operating lease liabilities?
- Over 5 years (2020 to 2025), Nuvation Bio's operating lease liabilities has grown at a -3.9% compound annual growth rate (CAGR), from $3.1M to $2.54M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Nuvation Bio's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude